Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for research in Seattle and Rochester is focused on preclinical and clinical studies of Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD), the two most common forms of dystrophy.
This is a collaborative venture between scientists and clinicians at the University of Washington, Fred
Hutchinson Cancer Research Center, Seattle Children’s Hospital and The University of Rochester and is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a branch of the National Institutes of Health (NIH).
Dr. Jeffrey Chamberlain at the University of Washington is the Director and Dr. Stephen Tapscott at the Fred Hutchinson Cancer Research Center are Co-directors of the Wellstone Center.
More about the members of the Seattle Wellstone MDCRC